AllPennyStocks.com IONS Edges Up After-Hours On FDA’s Green Light For Neurology Drug After Being Dragged Down By Ultragenyx’s Failed Trial
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

IONS Edges Up After-Hours On FDA’s Green Light For Neurology Drug After Being Dragged Down By Ultragenyx’s Failed Trial

Zanvastro is now approved for children and adults with Alexander disease, a rare and often fatal brain condition that affects fewer than one in a million people.

Other Penny Stock Movers

Residential Solar Issuer Surges 56% on $26M Venture Private Placement
AI Data Centers Are Being Rewired. One Critical Metal Is Moving With Them
Canadian Gold Explorer Gains 17% as Final Assays Complete Maiden Resource Database
Most Popular
{{ index + 1 }}


Back to Top